Get the app
US › Healthcare

biote Corp (BTMD)

US · Healthcare · Medical Care Facilities

$1.08-2.25%
Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue
$44.2M
Revenue YoY
-9.5%
Net profit
$-6.6M
Profit YoY
-306.1%
EPS
$0.10
EPS estimate
$0.03
Net margin
-14.8%

EPS came in at 0.10 against a street estimate of 0.03 — a beat of 233.3%.

Key statistics

Market cap
$37.6M
P/E
7.9
Forward P/E
5.2
P/B
2.96
Book value
$-2.38
EPS (TTM)
$0.14
52-week high
$3.26
52-week low
$1.00
50-day MA
$1.37
200-day MA
$1.91
Beta
1.69

Analyst view

Analysts rate biote Corp a strong buy (4 buy, 1 hold, 0 sell out of 5) with an average price target of $2.61.

Shareholding

Insiders
19.82%
Institutions
62.97%

Largest institutional holders

FundStake
325 Capital LLC15.86%
Bandera Partners LLC7.20%
Vanguard Capital Management, LLC3.85%
Acadian Asset Management LLC2.18%
Millennium Management LLC1.52%
Dimensional Fund Advisors, Inc.1.51%
BlackRock Inc1.28%
Citadel Advisors Llc1.05%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for biote Corp — free to start.

Open in the appGoogle PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncGilead Sciences IncAbbott LaboratoriesNovo Nordisk A/S

Data updated 2026-10-19.